Get the Stockscreener App
26.20
4.76%
-1.3097
Hikma Pharmaceuticals Plc Stock (HKMPF) Forecast
The Hikma Pharmaceuticals Plc (HKMPF) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.2954, representing a -95.05% decrease from the current price of $26.20. The highest analyst price target is $1.8444, and the lowest is $0.7464.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HKMPF Price Target
Average 3.1052
(-88.15% Downside)
Long-term HKMPF price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Hikma Pharmaceuticals Plc financial reports and earnings history, Hikma Pharmaceuticals Plc (HKMPF) stock could reach $22.01 by 2030, $74.80 by 2040 and $124.08 by 2050. See the projected annual prices until 2050 of the Hikma Pharmaceuticals Plc stock below:
- Hikma Pharmaceuticals Plc (HKMPF) is expected to reach an average price of $47.77 in 2035, with a high prediction of $49.07 and a low estimate of $47.58. This indicates an $82.35% rise from the last recorded price of $26.20.
- Hikma Pharmaceuticals Plc (HKMPF) stock is projected to chart a bullish course in 2040, with an average price target of $74.80, representing an $185.52% surge from its current level. The forecast ranges from a conservative $71.64 to a sky-high $74.80.
- Our analysts predict Hikma Pharmaceuticals Plc (HKMPF) to jump 275.42% by 2045, soaring from $91.74 to an average price of $98.35, potentially reaching $98.35. While $91.74 is the low estimate, the potential upside is significant.
- Hikma Pharmaceuticals Plc (HKMPF) stock is expected to climb by 2050, reaching an average of $118.46, a $352.19% jump from its current level. However, a wide range of estimates exists, with high and low targets of $124.08 and $118.77, respectively, highlighting the market's uncertainty.
Hikma Pharmaceuticals Plc Stock (HKMPF) Year by Year Forecast
Hikma Pharmaceuticals Plc Stock (HKMPF) Price Forecast for 2025
Hikma Pharmaceuticals Plc Stock (HKMPF) is expected to reach an average price of $4.2574 in 2025, with a high prediction of $8.5004 and a low estimate of $0.0143. This indicates an -83.75% fall from the last recorded price of $26.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $1.8444 | $0.7464 | $1.8444 | -92.96% |
| June, 2025 | $3.6731 | $1.1502 | $6.1961 | -85.98% |
| July, 2025 | $0.5152 | $0.5152 | $5.4489 | -98.03% |
| August, 2025 | $0.2316 | $0.2316 | $0.6675 | -99.12% |
| September, 2025 | $4.2288 | $0.0143 | $5.0439 | -83.86% |
| October, 2025 | $1.4999 | $0.6802 | $3.624 | -94.27% |
| November, 2025 | $0.8488 | $0.5094 | $1.5797 | -96.76% |
| December, 2025 | $1.1515 | $1.1515 | $3.8917 | -95.60% |
Hikma Pharmaceuticals Plc Stock (HKMPF) Price Forecast for 2026
The predicted value for Hikma Pharmaceuticals Plc (HKMPF) in 2026 is set at an average of $3.7564. Estimates vary from a peak of $7.4949 to a trough of $0.0178, indicating an -85.66% surge from the present price of $26.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.8027 | $0.4071 | $2.7627 | -89.30% |
| February, 2026 | $2.0131 | $1.6863 | $2.1098 | -92.32% |
| March, 2026 | $0.0563 | $0.0563 | $2.7395 | -99.79% |
| April, 2026 | $2.8631 | $1.6086 | $3.9458 | -89.07% |
| May, 2026 | $1.9126 | $0.5447 | $3.2805 | -92.70% |
| June, 2026 | $2.8102 | $0.0178 | $2.5952 | -89.27% |
| July, 2026 | $4.4512 | $4.04 | $5.1288 | -83.01% |
| August, 2026 | $0.6516 | $0.4352 | $4.3424 | -97.51% |
| September, 2026 | $6.2568 | $1.2317 | $6.2568 | -76.12% |
| October, 2026 | $5.5069 | $5.2169 | $6.3119 | -78.98% |
| November, 2026 | $2.4457 | $0.717 | $2.4457 | -90.66% |
| December, 2026 | $7.5349 | $3.6795 | $7.4949 | -71.24% |
Hikma Pharmaceuticals Plc Stock (HKMPF) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Hikma Pharmaceuticals Plc (HKMPF) is $7.0481, with a high forecast of $12.23 and a low forecast of $1.8692. This indicates an -73.09% decrease from the last price of $26.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.6203 | $2.9303 | $6.7926 | -90.00% |
| February, 2027 | $4.8873 | $1.8692 | $4.8873 | -81.34% |
| March, 2027 | $7.5706 | $6.4149 | $8.678 | -71.10% |
| April, 2027 | $5.4923 | $3.0214 | $7.9633 | -79.03% |
| May, 2027 | $7.6165 | $4.3119 | $7.4015 | -70.92% |
| June, 2027 | $9.134 | $8.7475 | $9.861 | -65.13% |
| July, 2027 | $5.532 | $4.1735 | $9.0005 | -78.88% |
| August, 2027 | $10.24 | $6.0874 | $10.24 | -60.90% |
| September, 2027 | $10.17 | $9.9244 | $11.04 | -61.20% |
| October, 2027 | $7.3014 | $5.3257 | $7.3014 | -72.13% |
| November, 2027 | $12.20 | $8.5105 | $12.20 | -53.42% |
| December, 2027 | $7.2537 | $7.5637 | $12.23 | -72.31% |
Hikma Pharmaceuticals Plc Stock (HKMPF) Price Forecast for 2028
In 2028, Hikma Pharmaceuticals Plc (HKMPF) is projected to reach an average price of $11.72, with a high projection of $16.96 and a low estimate of $6.4779. This indicates an -55.26% fall from the last price of $26.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $9.7183 | $6.4779 | $9.7183 | -62.90% |
| February, 2028 | $13.45 | $11.22 | $13.41 | -48.66% |
| March, 2028 | $10.14 | $7.6301 | $12.65 | -61.30% |
| April, 2028 | $12.42 | $9.1923 | $12.21 | -52.58% |
| May, 2028 | $13.82 | $13.46 | $14.59 | -47.26% |
| June, 2028 | $10.41 | $8.7822 | $13.66 | -60.25% |
| July, 2028 | $15.03 | $10.94 | $15.03 | -42.64% |
| August, 2028 | $14.82 | $14.63 | $15.78 | -43.41% |
| September, 2028 | $12.16 | $9.9344 | $12.16 | -53.59% |
| October, 2028 | $16.96 | $13.34 | $16.96 | -35.26% |
| November, 2028 | $11.89 | $12.20 | $16.96 | -54.62% |
| December, 2028 | $14.55 | $11.09 | $14.55 | -44.46% |
Hikma Pharmaceuticals Plc Stock (HKMPF) Price Forecast for 2029
The 2029 price forecast for Hikma Pharmaceuticals Plc Stock (HKMPF) is $17.57 on average, with a high prediction of $22.91 and a low estimate of $12.24. This represents an -32.92% decrease from the previous price of $26.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $16.99 | $16.03 | $18.15 | -35.16% |
| February, 2029 | $14.78 | $12.24 | $17.33 | -43.56% |
| March, 2029 | $17.23 | $14.07 | $17.01 | -34.23% |
| April, 2029 | $18.16 | $18.16 | $19.34 | -30.67% |
| May, 2029 | $15.29 | $13.39 | $18.50 | -41.62% |
| June, 2029 | $19.81 | $15.80 | $19.81 | -24.39% |
| July, 2029 | $19.67 | $19.34 | $20.53 | -24.91% |
| August, 2029 | $17.01 | $14.54 | $19.48 | -35.06% |
| September, 2029 | $21.72 | $18.17 | $21.72 | -17.10% |
| October, 2029 | $16.52 | $16.83 | $21.69 | -36.93% |
| November, 2029 | $19.38 | $15.70 | $19.38 | -26.02% |
| December, 2029 | $22.91 | $20.83 | $22.91 | -12.53% |
Hikma Pharmaceuticals Plc Stock (HKMPF) Price Forecast for 2030
Hikma Pharmaceuticals Plc Stock (HKMPF) is expected to reach an average price of $22.26 in 2030, with a high forecast of $27.66 and a low forecast of $16.85. This signifies an -15.04% decrease from the last price of $26.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $19.43 | $16.85 | $22.01 | -25.83% |
| February, 2030 | $22.04 | $18.95 | $21.82 | -15.88% |
| March, 2030 | $22.87 | $22.87 | $24.10 | -12.70% |
| April, 2030 | $20.59 | $18.00 | $23.18 | -21.40% |
| May, 2030 | $24.59 | $20.17 | $24.59 | -6.14% |
| June, 2030 | $24.35 | $24.05 | $25.28 | -7.03% |
| July, 2030 | $21.87 | $19.15 | $24.14 | -16.52% |
| August, 2030 | $26.47 | $23.00 | $26.47 | +1.06% |
| September, 2030 | $25.30 | $25.22 | $26.42 | -3.41% |
| October, 2030 | $24.21 | $20.30 | $24.21 | -7.58% |
| November, 2030 | $27.65 | $25.64 | $27.66 | +5.54% |
| December, 2030 | $22.31 | $22.62 | $26.69 | -14.83% |
6.25%
0.05%
Cap:
|
Volume (24h):